News Sections
FDA Approves New Eli Lilly Diabetes Drug
Updated May 5, 2013 12:09 AM | Filed under: Network Indiana
 Print    Archive    RSS

(UNDATED) - The Food and Drug Administration has approved a diabetes drug created in a collaborative effort between Eli Lilly and Connecticut-based Boehringer Ingelheim Pharmaceuticals.

Tradjenta lowers blood sugar in a glucose-dependent manner by increasing incretin levels.

The drug is approved to be used by people with type 2 diabetes in conjunction with diet and exercise.

« Previous Article
Next Article »

 Print    Archive    RSS

Have a question or comment about a news story? Send it to

Advertise with 1340 AM WBIW
Find more about Weather in Bedford, IN
Advertise with 1340 AM WBIW

1340 AM WBIW, Bedford's Place To Talk. Serving Lawrence and surrounding counties since 1948!

© 2018 Ad-Venture Media, Inc. All Rights Reserved. and Listen Live Powered by HPC

Advertise  |  Careers  |  Contests  |  About  |  Feedback  |  Public File